More recently, Kawano et al. reported a serial determination of PON plasma levels in one patient with chronic-phase CML, one in the advanced phase of CML, and in another patient affected by Ph’+ ALL [29]. This evidence concerns the gene PON1 and acute lymphoblastic leukemia.